Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01171664 · ClinicalTrials.gov registry record · Phase 2

Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects

A Phase 2 study of Seasonal Allergic Rhinitis, sponsored by Magna Pharmaceuticals.

Completed
Registry status
Phase 2
Development phase
100
Enrollment target
2
Study locations

NCT01171664 is a Phase 2 study of Seasonal Allergic Rhinitis that has completed, run by Magna Pharmaceuticals. The registered enrollment target is 100 participants, below the 662-participant average among 16 other Seasonal Allergic Rhinitis trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01171664, a Phase 2 study of Seasonal Allergic Rhinitis, has completed, sponsored by Magna Pharmaceuticals.

COMPLETED
Registry status
Phase 2
Development phase
100 participants
Enrollment target
2
Study locations

Study Summary

To report and compare total symptom scores, nasal symptom scores, post-nasal drip symptom scores, and adverse reactions in and between SAR subjects on active drug and SAR subjects on placebo.

Conditions Studied

Seasonal Allergic Rhinitis

Interventions

  • DRUG Placebo
  • DRUG STAHIST

Study Locations (2)

Indiana

  • The South Bend Clinic - South Bend

Kentucky

  • Family Allergy & Asthma Research Institute - Louisville

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2010-09
Est. Completion 2011-01
Phase Phase 2

Sponsor

Magna Pharmaceuticals

3 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01171664

The ClinicalTrials.gov registry entry for NCT01171664 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 662-participant average among 16 other Seasonal Allergic Rhinitis trials with a reported enrollment target (85% lower). The listed sponsor is Magna Pharmaceuticals, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Seasonal Allergic Rhinitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01171664 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Indiana, Kentucky.

Frequently Asked Questions

What is clinical trial NCT01171664 about?

NCT01171664 is a clinical study titled "Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) Subjects". To report and compare total symptom scores, nasal symptom scores, post-nasal drip symptom scores, and adverse reactions in and between SAR subjects on active drug and SAR subjects on placebo.

What is the current status of trial NCT01171664?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2010-09. Estimated completion is 2011-01.

What conditions does trial NCT01171664 study?

This clinical trial studies the following conditions: Seasonal Allergic Rhinitis.

What interventions are being tested in trial NCT01171664?

The interventions under investigation include: Placebo (DRUG), STAHIST (DRUG).

Who is sponsoring clinical trial NCT01171664?

This trial is sponsored by Magna Pharmaceuticals, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01171664 being conducted?

This trial has 2 study locations across Indiana, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Seasonal Allergic Rhinitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Seasonal Allergic Rhinitis

All registered trials for this condition

Indiana

All trials with a study site in Indiana

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.